Drugs Design and Process Chemistry: A Factuality Study of Recent Advance In Drug Delivery Systems A Comprehensive Review

Notice

This is an unedited manuscript accepted for publication and provided as an Article in Press for early access at the author’s request. The article will undergo copyediting, typesetting, and galley proof review before final publication. Please be aware that errors may be identified during production that could affect the content. All legal disclaimers of the journal apply.

Year : 2025 | Volume :15 | Issue : 01 | Page : –
    By

    Mohd. Wasiullah,

  • Piyush Yadav,

  • Shashikant Maury,

  • Neha,

  1. Principal, Department of Pharmacy, Prasad Institute of Technology, Jaunpur, Uttar Pradesh, India
  2. Academic Head, Department of Pharmacy, Prasad Institute of Technology, Jaunpur, Uttar Pradesh, India
  3. Principal, Department of Pharmacy, Prasad Institute of Technology, Jaunpur, Uttar Pradesh, India
  4. Scholar, Department of Pharmacy, Prasad Institute of Technology, Jaunpur, Uttar Pradesh,

Abstract

document.addEventListener(‘DOMContentLoaded’,function(){frmFrontForm.scrollToID(‘frm_container_abs_153375’);});Edit Abstract & Keyword

Recent years have seen significant advances in drug design and process chemistry, mostly due to breakthroughs in drug delivery technologies. This study provides a thorough examination of current developments in drug delivery, emphasizing strategies that improve therapeutic efficacy, reduce adverse effects, and maximize pharmacokinetic profile. The effects of several strategies on drug stability, solubility, and bioavailability are examined, including controlled-release systems, targeted delivery methods, and nanoparticle-based delivery. This review also highlights the significance of green chemistry and sustainable practices while examining the function of process chemistry in scaling up drug manufacture to satisfy regulatory criteria. We analyze current trends, issues, and potential paths in the subject using a factuality (flexible and factual) approach, offering a fundamental resource for scholars

Keywords: chemotherapy, tumor, nanoparticles, drug delivery, pharmacokinetic

[This article belongs to Research & Reviews : A Journal of Biotechnology (rrjobt)]

How to cite this article:
Mohd. Wasiullah, Piyush Yadav, Shashikant Maury, Neha. Drugs Design and Process Chemistry: A Factuality Study of Recent Advance In Drug Delivery Systems A Comprehensive Review. Research & Reviews : A Journal of Biotechnology. 2025; 15(01):-.
How to cite this URL:
Mohd. Wasiullah, Piyush Yadav, Shashikant Maury, Neha. Drugs Design and Process Chemistry: A Factuality Study of Recent Advance In Drug Delivery Systems A Comprehensive Review. Research & Reviews : A Journal of Biotechnology. 2025; 15(01):-. Available from: https://journals.stmjournals.com/rrjobt/article=2025/view=0

document.addEventListener(‘DOMContentLoaded’,function(){frmFrontForm.scrollToID(‘frm_container_ref_153375’);});Edit

References

  1. Rayaprolu BM, Strawser JJ, Anyarambhatla G. Excipients in parenteral formulations: selection considerations and effective utilization with small molecules and biologics. Drug development and industrial pharmacy. 2018 Oct 3;44(10):1565-71.
  2. Vargason AM, Anselmo AC, Mitragotri S. The evolution of commercial drug delivery technologies. Nature biomedical engineering. 2021 Sep;5(9):951-67.
  3. Alqahtani MS, Kazi M, Alsenaidy MA, Ahmad MZ. Advances in oral drug delivery. Frontiers in pharmacology. 2021 Feb 19;12:618411.
  4. Danhier F, Feron O, Préat V. To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. Journal of controlled release. 2010 Dec 1;148(2):135-46.
  5. Agrahari V. Novel drug delivery systems, devices, and fabrication methods. Drug Delivery and Translational Research. 2018 Apr;8:303-6.
  6. Patra JK, Das G, Fraceto LF, Campos EV, Rodriguez-Torres MD, Acosta-Torres LS, Diaz-Torres LA, Grillo R, Swamy MK, Sharma S, Habtemariam S. Nano based drug delivery systems: recent developments and future prospects. Journal of nanobiotechnology. 2018 Dec;16:1-33.
  7. Li X, Szewczuk MR, Malardier-Jugroot C. Folic acid-conjugated amphiphilic alternating copolymer as a new active tumor targeting drug delivery platform. Drug design, development and therapy. 2016 Dec 15:4101-10.
  8. Mehrdadi S. Drug delivery of solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) to target brain tumors. Advanced Pharmaceutical Bulletin. 2022 Nov 5;13(3):512.
  9. Doytchinova I. Drug design—past, present, future. Molecules. 2022 Feb 23;27(5):1496.
  10. Hughes JP, Rees S, Kalindjian SB, Philpott KL. Principles of early drug discovery. British journal of pharmacology. 2011 Mar;162(6):1239-49.
  11. Fogel DB. Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: a review. Contemporary clinical trials communications. 2018 Sep 1;11:156-64.
  12. Patton EE, Zon LI, Langenau DM. Zebrafish disease models in drug discovery: from preclinical modelling to clinical trials. Nature Reviews Drug Discovery. 2021 Aug;20(8):611-28.
  13. Cassar S, Adatto I, Freeman JL, Gamse JT, Iturria I, Lawrence C, Muriana A, Peterson RT, Van Cruchten S, Zon LI. Use of zebrafish in drug discovery toxicology. Chemical research in toxicology. 2019 Oct 18;33(1):95-118.
  14. MacRae CA, Peterson RT. Zebrafish as tools for drug discovery. Nature reviews Drug discovery. 2015 Oct;14(10):721-31.
  15. Guerra-Farfan E, Garcia-Sanchez Y, Jornet-Gibert M, Nuñez JH, Balaguer-Castro M, Madden K. Clinical practice guidelines: The good, the bad, and the ugly. Injury. 2023 May 1;54:S26-9.
  16. Cięszczyk N, Czech M, Pronicki Ł, Gujski M. Knowledge and Beliefs about Clinical Trials among Adults in Poland: A Cross-Sectional Study. Clinics and Practice. 2024 Jul 2;14(4):1285-95.
  17. Jose C, Amra K, Bhavsar C, Momin MM, Omri A. Polymeric lipid hybrid nanoparticles: properties and therapeutic applications. Critical Reviews™ in Therapeutic Drug Carrier Systems. 2018;35(6).
  18. Pérez-Herrero E, Fernández-Medarde A. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy. European journal of pharmaceutics and biopharmaceutics. 2015 Jun 1;93:52-79.
  19. Choudhury H, Gorain B, Pandey M, Khurana RK, Kesharwani P. Strategizing biodegradable polymeric nanoparticles to cross the biological barriers for cancer targeting. International journal of pharmaceutics. 2019 Jun 30;565:509-22.
  20. Rizwanullah M, Alam M, Harshita, Mir SR, Rizvi MM, Amin S. Polymer-lipid hybrid nanoparticles: A next-generation nanocarrier for targeted treatment of solid tumors. Current Pharmaceutical Design. 2020 Mar 1;26(11):1206-15.
  21. Mohanty A, Uthaman S, Park IK. Utilization of polymer-lipid hybrid nanoparticles for targeted anti-cancer therapy. Molecules. 2020 Sep 23;25(19):4377.
  22. Girelli AM, Astolfi ML, Scuto FR. Agro-industrial wastes as potential carriers for enzyme immobilization: A review. Chemosphere. 2020 Apr 1;244:125368.
  23. Chandrasekhar SA, Satyanarayana KG, Pramada PN, Raghavan P, Gupta TN. Review processing, properties and applications of reactive silica from rice husk—an overview. Journal of materials science. 2003 Aug;38:3159-68.
  24. Girelli AM, Scuto FR. Eggshell membrane as feedstock in enzyme immobilization. Journal of biotechnology. 2021 Jan 10;325:241-9.
  25. Kessi E, Arias JL. Using natural waste material as a matrix for the immobilization of enzymes: Chicken eggshell membrane powder for β-galactosidase immobilization. Applied biochemistry and biotechnology. 2019 Jan 15;187:101-15.
Regular Issue Subscription Review Article
Volume 15
Issue 01
Received 14/12/2024
Accepted 07/01/2025
Published 01/02/2025
109